SecBot SecBot
8-K ·Filed Apr 28, 2026

PIIIW

P3 Health Partners Inc.
BEARISH
Impact 6/10
Horizonmonths Processed6mo ago SEC0001832511-26-000018
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

Monitor the company's next quarterly report for cash burn and ability to service preferred dividends. The warrant overhang will likely cap common stock upside. Watch for additional insider sales or further debt/equity raises.

DirectionBearish
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d
PIIIW ▲ +96.92% at T+60d
SHORT call ✗ call lost -96.92% · α vs SPY -92.81% · entry $0.006500 → $0.0128
Entry = T+0 close
Apr 28, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.02%
$0.006500
settled 6mo ago
T+5d
0.00%
call 0.00% · α +3.11%
$0.006500
settled 6mo ago
T+20d
0.00%
call 0.00% · α +6.05%
$0.006500
settled 5mo ago
T+60d
+96.92%
call -96.92% · α -92.81%
$0.0128
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

P3 Health Partners raised up to $70 million via a private placement of Series D 19.5% Cumulative Preferred Stock and warrants, with proceeds for general corporate purposes. The preferred stock carries a 19.5% cumulative dividend (payable in cash or PIK) and the warrants represent potential dilution of ~46% of the outstanding common stock. This high-cost capital raise signals financial strain and will pressure cash flow and common equity.

Key Financial Metrics

Deal Value
$70.0M
Offering Size
$70.0M

Key Facts

  • Entered into Securities Purchase Agreement for up to $70M aggregate commitment
  • Issuing Series D 19.5% Cumulative Preferred Stock at $100 stated value per share
  • Warrants to purchase common stock at 0.66333% of outstanding per $1M of preferred acquired
  • Preferred dividends are cumulative, can be paid in cash or PIK
  • Warrants have a 7-year term, exercise price set at Nasdaq Minimum Price
  • Company filed Certificates of Designation for Series A, B, C, D preferred stock
  • Registration Rights Agreement filed to register resale of warrant shares

Financial Impact

Up to $70M in preferred stock at 19.5% annual dividend ($13.65M/yr) plus warrant dilution of up to 46% of common stock

dilutioncash flowinterest expense

Risk Factors

  • Preferred dividend obligation may strain liquidity
  • Warrant dilution of ~46% depresses common equity value
  • High dividend rate (19.5%) reflects poor credit quality
  • Potential PIK dividend election would increase preferred share count and future obligations

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001832511-26-000018
Document: piii-20260427exhibit102.htm0001832511-26-000018
Document: piii-20260427exhibit103.htm0001832511-26-000018
Document: piii-20260427exhibit104.htm0001832511-26-000018
2 reports for PIIIW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PIIIW — sortable, filterable
TypeNow
May 15, 2026
23w ago
8-K
BULLISH ★ 6/10
$0.006500 $0.0188▲ +189.23%▲ +184.38%—
Apr 28, 2026
25w ago
8-K
BEARISH ★ 6/10
$0.006500 $0.0128▼ −96.92%▼ −92.81%—
Showing 2 of 2

US Market Status

Market Open — Closes in 2h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026